Enliven Therapeutics, Inc. (ELVN) Insider Trading

Name: Enliven Therapeutics, Inc. (ELVN) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 21, 2026): Hohl Benjamin (CHIEF FINANCIAL OFFICER): Exercise/Conversion of 3,982 shares, $59.1K.

Get alerted when insiders trade ELVN

Email address

Loading company data...

Beta

Loading company details...

Beta